Latest News Archive
Please select Category, Year, and then Month to display items
13 August 2024
|
Story Anthony Mthembu
|
Photo Sibahle Dayimani and Amandla Kulu
Prof Peter Roseel, Managing Director of Management Consulting and Research – a spin-off of the Catholic University of Leuven in Belgium; and Prof Nicolene Barkhuizen, Director of the UFS Business School.
The Business School at the University of the Free State (UFS) hosted Prof Peter Rosseel, Managing Director of Management Consulting and Research – a spin-off of the Catholic University of Leuven in Belgium – for a guest lecture during his visit to the UFS Faculty of Economic and Management Sciences (EMS).
The guest lecture took place on 19 July 2024 in the Business School Auditorium and was attended by academics from the UFS.
Reflecting on the lecture
The lecture presented by Prof Rosseel focused on how combining strategy, strategy implementation, culture transformation, leadership, and learning successfully leads to sustainable growth, creates engagement, and delivers tangible results. Throughout the lecture, Prof Rosseel spoke about how experts tend to make bad leaders and therefore stop change from happening within an organisation. In fact, he highlighted that, “Experts stop change from happening within the workplace because experts, by definition, look through the eyes of their expertise, but you cannot reduce the world to different forms of expertise, as it is holistic.” As such, he argued that to change an organisation, one must see things from the point of view of others.
Furthermore, Prof Rosseel delved deeper into the hierarchical operating model within organisations. He indicated that the above model should be one community within organisations; however, unfortunately it is not. This is because organisations are made up of several departments such as finance and human resources. As such, he regards these departments to be silos that could prove to be detrimental to organisations, as each silo can create its own culture as opposed to an organisational culture. These are some of the points he discussed throughout the lecture.
After the lecture concluded, the audience had the opportunity to engage with Prof Rosseel on his viewpoints. In fact, Lyle Markham, Academic Head of Department and Lecturer in Industrial Psychology at the UFS, was one of the audience members and described the lecture as insightful.
New research informs improved treatment of brain inflammation
2017-10-13
Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish
Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.
Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.
Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.
Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology